The HEP-COVID Trial
Event: ESC Congress 2021 - The Digital Experience
Topic: Venous Thromboembolism
Session: Latest Science in COVID-19
State of the Art - Optimizing the prevention of venous thromboembolism
Event: ESC Congress 2018
Topic: Treatment
Session: Progress in anticoagulation for venous thromboembolism
MARINER.
Event: ESC Congress 2018
Topic: Prevention
Session: Meet the trialist - MARINER - Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk
MARINER - Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk
Event: ESC Congress 2018
Topic: Prevention
Session: Hot Line Session 1
The journey continues: looking ahead with dabigatran.
Event: ESC CONGRESS 2014
Topic: Thrombosis and coagulation
Session: Changing the face of anticoagulation: 5 years since RE-LY®
ESC 365 is supported by
